# Neuroimaging Study

> **NCT03618186** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Mayo Clinic** · enrollment: 240 (estimated)

## Conditions studied

- Cognitive Impairment

## Interventions

- **COMBINATION_PRODUCT:** Tau PET scan

## Key facts

- **NCT ID:** NCT03618186
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2018-11-26
- **Primary completion:** 2030-05
- **Final completion:** 2030-05
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03618186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03618186, "Neuroimaging Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03618186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*